<DOC>
	<DOC>NCT00673608</DOC>
	<brief_summary>This study will evaluate the change in cardiac iron load over a 53 week period measured by MRI in 2 cohorts of patients</brief_summary>
	<brief_title>Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Hemoglobinopathies</mesh_term>
	<mesh_term>Anemia, Diamond-Blackfan</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>Inclusion criteria: Male or female WITH haemoglobinopathy, Myelodysplastic Syndromes or other inherited or acquired anaemia (e.g. MPD, Diamondblackfan anaemia and other rare anaemias) patients â‰¥ 18 years and weighing &gt;40kg. Lifetime minimum of &gt; 20 units of packed red blood cell transfusions Normal or minimally abnormal cardiac function Exclusion criteria: Contraindication to MRI scans High risk myelodysplastic syndromes patients and patients with other haematological and nonhaematological malignancies who are not expected to benefit from chelation therapy due to the rapid progression of their disease Patients with uncontrolled high blood pressure An organ transplant less than 3 months previously Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Haemoglobinopathies,</keyword>
	<keyword>Myelodysplastic Syndromes,</keyword>
	<keyword>Transfusional iron overload,</keyword>
	<keyword>cardiac iron load</keyword>
</DOC>